Long-Term Safety and Effectiveness of Adalimumab for the Treatment of Japanese Patients With Rheumatoid Arthritis: 3-Year Results From a Postmarketing Surveillance of 552 Patients

Modern Rheumatology - United Kingdom
doi 10.1080/14397595.2017.1304159
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Effectiveness and Safety of Tocilizumab: Postmarketing Surveillance of 7901 Patients With Rheumatoid Arthritis in Japan

Journal of Rheumatology
RheumatologyAllergyImmunology
2013English

Long-Term Treatment of Rheumatoid Arthritis With Adalimumab

Open Access Rheumatology: Research and Reviews
Rheumatology
2013English

Long-Term Follow-Up of Adalimumab Monotherapy for Rheumatoid Arthritis in Japanese Patients: A Report of Six Cases

Rheumatology International
RheumatologyAllergyImmunology
2011English

Safety and Effectiveness of Adalimumab in Patients With Rheumatoid Arthritis Over 5 Years of Therapy in a Phase 3b and Subsequent Postmarketing Observational Study

Arthritis Research and Therapy
RheumatologyAllergyImmunology
2014English

Effectiveness, Safety, and Methotrexate Dose-Tapering Pattern Over Two Years of Treatment With Adalimumab and ≥12 Mg/Week Methotrexate for Early Rheumatoid Arthritis: Results of the HAWK Postmarketing Surveillance Study in Japan

Modern Rheumatology
MedicineRheumatology
2019English

SAT0172 Long-Term Efficacy With 5-Year-Radiographic Results and Safety of Sarilumab in Combination With Csdmards in Patients With Rheumatoid Arthritis

2018English

Risk of Malignancies in Patients With Rheumatoid Arthritis Treated With Rituximab: Analyses of Global Postmarketing Safety Data and Long-Term Clinical Trial Data

Rheumatology and Therapy
2019English

Long-Term Safety of Adalimumab in Adult Patients With Plaque Psoriasis

British Journal of Dermatology
DermatologyMedicine
2019English

OP0021 Efficacy and Safety Results of a Phase Iii Study Comparing Fkb327, an Adalimumab Biosimilar, With the Adalimumab Reference Product in Patients With Active Rheumatoid Arthritis

2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy